ArticleBMJ nutrition, prevention & health2026
Optimising enteral feeding prevents postnatal growth faltering in preterm infants: a retrospective cohort study.
Article in BMJ nutrition, prevention & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite advances in neonatal care, many preterm infants continue to experience growth faltering, with long-term consequences. We aimed to identify early, modifiable feeding-related risk factors and develop machine learning models to predict growth faltering at discharge. Methods: We retrospectively analysed 700 preterm infants (≤34 weeks gestational age (GA), ≤1800 g birth weight (BW)) admitted to a single level IV neonatal intensive care unit between 2014 and 2022, representing a relatively homogeneous population with standardised feeding practices. Over 100 demographic, clinical and nutritional variables, including parenteral and enteral intake during the first 28 days, were evaluated. Growth faltering was defined as a longitudinal decline in weight z-score of ≥1.2 SD from birth to 36 weeks postmenstrual age, rather than an absolute cross-sectional threshold. Supervised machine-learning models were trained using a 70% training and 30% testing split. Results: Growth faltering occurred in 17.7% (n=124). Affected infants had lower GA, lower BW and greater oxygen dependence at day of life 28 (all p<0.001). Although both enteral feeding volume and caloric intake were lower among infants with growth faltering, differences in enteral volume emerged earlier and persisted more strongly over time. The final predictive model demonstrated good discrimination (area under the curve=0.85). In adjusted models evaluating individual nutritional exposures, both enteral feeding volume and caloric intake were significantly associated with reduced odds of growth faltering. However, enteral volume demonstrated earlier divergence and a greater consistency across time points. Conclusions: Although both volume and caloric intake were significant when modelled independently, enteral feeding volume emerged as the more robust and clinically informative predictor, likely reflecting feeding tolerance and advancement decisions. Combining dynamic nutritional monitoring with artificial intelligence-based prediction tools may enable earlier identification of at-risk infants and guide individualised nutrition strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.